RoCCPORT

• Research type

  Research Study

• Full title

  A Prospective Cohort Study of Patients with Refractory or Unexplained Chronic Cough measuring Cough Variability and Burden on Patients’ Lives

• IRAS ID

  357290

• Contact name

  Amardeep Heer

• Contact email

  a.heer@nhs.net

• Sponsor organisation

  GlaxoSmithKline Research and Development Limited

• Duration of Study in the UK

  1 years, 0 months, 24 days

• Research summary

  This study is a multinational, multi-center, observational, prospective, cohort study of patients with RCC/UCC and patients without RCC/UCC using primary data collection. Each patient will participate in the study for a 4-week period (29 days), where they will be asked to complete ePRO questionnaires at specific timepoints and wear a cough monitoring device (smartwatch). No treatment will be provided as a result of participating in this study. Investigators will prescribe treatments based on usual clinical practice. A saliva sample will be collected in RCC/UCC patients that have consented to the optional genetic research.

• REC name

  South Central - Hampshire A Research Ethics Committee

• REC reference

  25/SC/0306

• Date of REC Opinion

  14 Oct 2025

• REC opinion

  Further Information Favourable Opinion